Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics

Summary

Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×10⁷ ml^-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.

Supported by grant (NIH R01-HL-095868).

Keywords

Thrombolysis / thrombolytic agents - ultrasound analysis - imaging

• References

• 1 Sobbe A. et al. Thrombolysis by ultrasound. Die Ultraschallauflösung von Thromben 1974; 52: 1117-1121.
• 2 Luo H. et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation 1996; 94: 775-778.
• 3 Nishioka T. et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study. J Am Coll Cardiol 1997; 30: 561-568.
• 4 Huai L. et al. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998; 89: 171-177.
• 5 Birnbaum Y. et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998; 97: 130-134.
• 6 Miyamoto T. et al. Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study. J Am Coll Cardiol 2003; 41: 1623-1627.
• 7 Rosenschein U. et al. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial): Results of the feasibility phase. Circulation 1997; 95: 1411-1416.
• 8 Alexandrov AV. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. New Engl J Med 2004; 351: 2170-2178.
• 9 Daffertshofer M. et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator – Results of a phase II clinical trial. Stroke 2005; 36: 1441-1446.
• 10 Alexandrov AV, Barlinn K. Taboos and opportunities in sonothrombolysis for stroke. Int J Hyperthermia 2012; 28: 397-404.
• 11 Pfaffenberger S. et al. Ultrasound thrombolysis. Thromb Haemost 2005; 94: 26-36.
• 12 Soltani A. et al. Sonothrombolysis: An Emerging Modality for the Treatment of Acute Ischemic and Hemorrhagic Stroke. Transl Stroke Res 2011; 02: 159-170.
• 13 Molina CA. et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-429.
• 14 Dinia L. et al. Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding. Neurology 2009; 73: 775-780.
• 15 Kutty S. et al. Sonothrombolysis of intra-catheter aged venous thrombi using microbubble enhancement and guided three-dimensional ultrasound pulses. J Am Soc Echocardiogr 2010; 23: 1001-1006.
• 16 Pagola J. et al. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Stroke 2007; 38: 2931-2934.
• 17 Weller GER. et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005; 65: 533-539.
• 18 Rubiera M. et al. Do Bubble Characteristics Affect Recanalization in Stroke Patients Treated with Microbubble-Enhanced Sonothrombolysis?. Ultrasound Med Biol 2008; 34: 1573-1577.
• 19 Leeman JE. et al. Effect of Acoustic Conditions on Microbubble-Mediated Microvascular Sonothrombolysis. Ultrasound Med Biol 2012; 38: 1589-1598.
• 20 Datta S. et al. Ultrasound-Enhanced Thrombolysis Using Definity® as a Cavitation Nucleation Agent. Ultrasound Med Biol 2008; 34: 1421-1433.
• 21 Prokop AF. et al. Cavitational Mechanisms in Ultrasound-Accelerated Fibrinolysis. Ultrasound Med Biol 2007; 33: 924-933.
• 22 Shi WT. et al. Investigation of effectiveness of microbubble stable cavitation in thrombolysis. IEEE Ultrasonics Symposium 2010; 330-333.
• 23 Chuang YH. et al. Effects of ultrasound-induced inertial cavitation on enzymatic thrombolysis. Ultrasonic Imag 2010; 32: 81-90.
• 24 Mizushige K. et al. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: Dependence on microbubble structure. Ultrasound Med Biol 1999; 25: 1431-1437.
• 25 Chen SC. et al. In vitro evaluation of ultrasound-assisted thrombolysis using a targeted ultrasound contrast agent. Ultrasonic Imag 2010; 31: 235-246.
• 26 Chen H. et al. Observations of translation and jetting of ultrasound-activated microbubbles in mesenteric microvessels. Ultrasound Med Biol 2011; 37: 2139-2148.
• 27 Chen H. et al. Microbubble dynamics in microvessels: Observations of microvessel dilation, invagination and rupture. IEEE Ultrasonics Symposium 2008; 1163-1166.
• 28 Fong SW. et al. Numerical analysis of a gas bubble near bio-materials in an ultrasound field. Ultrasound Med Biol 2006; 32: 925-942.
• 29 Postema M. et al. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys 2005; 32: 3707-3711.
• 30 Sankin GN, Zhong P. Interaction between shock wave and single inertial bubbles near an elastic boundary. Phys Rev E 2006; 74: 046304.
• 31 Devcic-Kuhar B. et al. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro. Thromb Haemost 2004; 92: 980-985.
• 32 Pfaffenberger S. et al. 2 MHz ultrasound enhances t-PA-mediated thrombolysis: Comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves. Thromb Haemost 2003; 89: 583-589.
• 33 Nedelmann M. et al. Low-frequency ultrasound induces nonenzymatic thrombolysis in vitro. J Ultrasound Med 2002; 21: 649-656.
• 34 Petit B. et al. In Vitro Sonothrombolysis of Human Blood Clots with BR38 Microbubbles. Ultrasound Med Biol 2012; 38: 1222-1233.
• 35 Caskey CF. et al. Microbubble tunneling in gel phantoms. J Acoust Soc Am 2009; 125: EL183-EL9.
• 36 Acconcia C. et al. Investigating the interaction between acoustically stimulated microbubbles and fibrin clots. AIP Confer Proc 2012; 1503: 250-255.
• 37 Wu J. et al. Improved Sonothrombolysis from a Modified Diagnostic Transducer Delivering Impulses Containing a Longer Pulse Duration. Ultrasound Med Biol. 2014. Epub ahead of print.
• 38 Sutton JT. et al. Clot Retraction Affects the Extent of Ultrasound-Enhanced Thrombolysis in an Ex Vivo Porcine Thrombosis Model. Ultrasound Med Biol 2013; 39: 813-824.
• 39 Hitchcock KE. et al. Ultrasound-Enhanced rt-PA Thrombolysis in an ex vivo Porcine Carotid Artery Model. Ultrasound Med Biol 2011; 37: 1240-1251.
• 40 Tiukinhoy-Laing SD. et al. Ultrasound-facilitated thrombolysis using tissueplasminogen activator-loaded echogenic liposomes. Thromb Res 2007; 119: 777-784.
• 41 Altar S. et al. Augmentation of in-vitro clot dissolution by low frequency highintensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 2001; 11: 223-228.
• 42 Hua X. et al. Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: A primary research. J Thromb Thrombol 2010; 30: 29-35.
• 43 Wu Y. et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998; 33: 880-885.
• 44 Wang B. et al. Thrombolysis effect of a novel targeted microbubble with low-frequency ultrasound in vivo. Thrombosis and Haemostasis 2008; 100: 356-361.
• 45 Hagisawa K. et al. Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: In vitro and in vivo study. J Thromb Haemost 2013; 11: 1565-1573.
• 46 Xie F. et al. Treatment of Acute Intravascular Thrombi With Diagnostic Ultrasound and Intravenous Microbubbles. J Am Coll Cardiol : Cardiovascular Imag 2009; 02: 511-518.
• 47 Xie F. et al. Detection of Intravascular Cavitational Activity during Treatment of Deep Vessel Thromboses with Diagnostic Ultrasound and Intravenous Microbubbles. Circulation Suppl 2007; 116: II–646.